MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR)
Condition(s):de Novo or Restenosis LesionsLast Updated:October 16, 2023Completed
Hide Studies Not Open or Pending
Condition(s):de Novo or Restenosis LesionsLast Updated:October 16, 2023Completed
Condition(s):Coronary Heart DiseaseLast Updated:November 18, 2023Not yet recruiting
Condition(s):Coronary Artery Disease; Coronary Stenosis; Stent Restenosis; Left Main Coronary Artery Disease; Chronic Total Occlusion of Coronary ArteryLast Updated:January 24, 2022Recruiting
Condition(s):DES In-stent StenosisLast Updated:August 27, 2021Completed
Condition(s):Coronary Artery DiseaseLast Updated:December 31, 2015Terminated
Condition(s):Vertebral Artery StenosisLast Updated:September 15, 2005Unknown status
Condition(s):Ischemic Heart Disease; RestenosisLast Updated:June 10, 2010Completed
Condition(s):Coronary DiseaseLast Updated:January 11, 2008Completed
Condition(s):Restenosis or Adverse Cardiovascular EventLast Updated:July 28, 2015Completed
Condition(s):Coronary Artery Disease; Stable Angina; Unstable AnginaLast Updated:June 7, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.